Over the past decade, hospitals and health systems have increasingly adopted interventions to address the needs of patients with substance use disorders. The Opioid Use Disorder (OUD) Cascade of Care provides a framework for organizing and tracking patient health milestones over time and can assist health systems in identifying areas of intervention to maximize the impact of evidence-based services. However, detailed protocols are needed to guide health systems in how to operationalize the OUD Cascade and track outcomes using electronic health records. In this paper, we describe the process of operationalizing and applying the OUD Cascade in a large, urban, public hospital system. Through this case example, we describe the technical processes around data mining, as well as the decision-making processes, challenges encountered, lessons learned from compiling preliminary patient data and defining stages and outcome measures for the OUD Cascade of Care, and preliminary data We identified 33,616 (26.17% female) individuals with an OUD diagnosis. Almost half (48%) engaged with addiction services, while only 10.7% initiated medication-based treatment in an outpatient setting, 6.7% had timely follow-up, and 3.5% were retained for a minimum of 6 months. The current paper serves as a primer for other health systems seeking to implement data-informed approaches to guide more efficient care and improved substance use-related outcomes. An OUD Cascade of Care must be tailored to local systems based on inherent data limitations and services design with an emphasis on early stages wherein drop-off is the greatest.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00952990.2024.2302500DOI Listing

Publication Analysis

Top Keywords

oud cascade
20
cascade care
16
health systems
16
opioid disorder
8
health
7
cascade
6
oud
6
care
5
systems
5
application opioid
4

Similar Publications

Background: Between 2012-2022 opioid-related overdose deaths in the United States, including Washington State, have risen dramatically. Opioid use disorder (OUD) is a complex, chronic, and criminalized illness with biological, environmental, and social causes. One-fifth of people with OUD have recent criminal-legal system involvement; > 50% pass through WA jails annually.

View Article and Find Full Text PDF

Background: In the United States, hepatitis C virus (HCV) diagnoses among reproductive-aged women are increasing amidst the ongoing opioid and drug overdose epidemic. While previous studies document racial and ethnic disparities in HCV testing and treatment in largely male populations, to our knowledge no national studies analyze these outcomes in reproductive-aged women with opioid use disorder (OUD).

Methods: We analyzed data from a cohort of reproductive-aged women (aged 15-44 years) with diagnosed OUD captured in the TriNetX Research Network, a network of electronic health records from across the United States.

View Article and Find Full Text PDF

Reframing conceptualizations of primary care involvement in opioid use disorder treatment.

BMC Prim Care

September 2024

Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Background: Opioid-related harms and opioid use disorder (OUD) are health priorities requiring urgent policy responses. There have been many calls for improved OUD care in primary care, as well as increasing involvement of primary care providers in countries like Canada and Australia, which have been experiencing high rates of opioid-related harms.

Methods: Using Starfield's 4Cs conceptualization of primary care functions, we examined how and why primary care systems may be suited towards, or pose challenges to providing OUD care, and identified health system opportunities to address these challenges.

View Article and Find Full Text PDF

The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections.

Drug Alcohol Depend

October 2024

Yale School of Medicine, Section of Infectious Diseases, New Haven, CT, United States; APT Foundation, New Haven, CT, United States; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, United States; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT,  United States; Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, CT, United States. Electronic address:

Background: Opioid use disorder (OUD) significantly impacts individual and public health and exacerbated further by concurrent infectious diseases. A syndemic approach is needed to address the intertwined OUD, HIV, and HCV epidemics, including the expanded use of medications for opioid use disorder (MOUD).

Methods: To identify MOUD scale-up opportunities, we conducted a retrospective cohort study, representing commercially insured persons, and created the OUD care continuum, including HIV and HCV influences in adults (18-64 years) newly diagnosed with OUD in 2019 using Merative MarketSan data.

View Article and Find Full Text PDF

Buprenorphine treatment and clinical outcomes under the opioid use disorder cascade of care.

Drug Alcohol Depend

October 2024

Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Dr., New York, NY 10032, United States; Research Foundation for Mental Hygiene, 1051 Riverside Dr, New York, NY 10032, United States.

Article Synopsis
  • Most patients engaged in treatment for opioid use disorder (OUD) initially, but retention dropped significantly over time, with only 17.1% remaining in treatment after 24 months.
  • Data showed that patients with opioid-positive tests at the start had a lower chance of achieving continuous abstinence, while those who tested opioid-negative had higher success rates.
  • Early achievement of abstinence was crucial; patients who maintained sobriety for the first 6 months were much more likely to stay in treatment for the following year or two, highlighting the need for interventions aimed at supporting early stability in high-risk individuals.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!